ARTICLE | Company News
Boulder Diagnostics Inc., Multimmune deal
January 18, 2010 8:00 AM UTC
Boulder Diagnostics will develop a blood-based heat shock protein 70 (Hsp70) lateral flow point-of-care test for Multimmune to determine which patients would benefit from hsp-70-derived treatments. T...